Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
DOACs versus LMWH in Prevention of VTE Recurrence in Cancer Patients
Author(s): Patricia Noreen L Bueno , William Bernard N Ong , Frinz Moey C Rubio , et al Added: 9 months ago
ESC 25: ESVM Guidelines on Interventional Treatment of VTE
Author(s): Oliver Schlager Added: 5 months ago
ESC Congress 2025 - New guidelines for catheter-based VTE therapy emphasise the importance of involving vascular experts, and performing procedures in experienced centers.Dr Oliver Schlager (Medical University of Vienna, AT) joins us to discuss the newly released 2025 ESVM Guidelines on Interventional Treatment of Venous Thromboembolism, endorsed by European national societies of Vascular… View more

Guidelines & Statements

Intervention
ESC 25: The HI-PRO Trial
Author(s): Gregory Piazza Added: 5 months ago
ESC Congress 2025 - HI-PRO shows apixaban 2.5mg twice daily reduced the risk of symptomatic recurrent venous thromboembolism when compared to placebo at 12 months.Dr Gregory Piazza (Brigham and Women's Hospital, US) joins us to discuss findings from the HI-PRO trial, evaluating extended-duration low-intensity apixaban versus placebo for secondary prevention in high-risk patients with provoked… View more

Anticoagulation

Vascular Disease and Surgery
ACC 25 Late-Breaking Discussion: The API-Cat Study
Author(s): Harriette Van Spall , Isabelle Mahé Added: 10 months ago
ACC 25 - The API-CAT Study shows reduced-dose apixaban is non-inferior to full-dose apixaban for extended anticoagulation in patients with active cancer who have completed 6 months of anticoagulant therapy for venous thromboembolism (VTE).Late-Breaker host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Prof Isabelle Mahe (Paris Cite University, Paris, FR) to discuss the… View more

Anticoagulation

Vascular Disease and Surgery
AHA 23: KABUKI: DOAC in Pts with CTEPH
Author(s): Kazuya Hosokawa , Abe Kotaro Added: 2 years ago
AHA 2023 — Dr Kazuya Hosokawa and Dr Abe Kotaro (Kyushu University Hospital, JP) join us to share the findings of the KABUKI trial (NCT04730037). The aim of KABUKI (Daiichi Sankyo) is to assess whether edoxaban, a direct factor Xa inhibitor, is noninferior to warfarin in preventing worsening of chronic thromboembolic pulmonary hypertension (CTEPH).This investigator-initiated, multicenter, phase 3… View more

Prevention & Chronic Conditions
Viewpoint on the 2025 ESC Guidelines for CV Disease and Pregnancy
Author(s): Ju-Le Tan Added: 1 month ago

CV Disease in Special Populations
Job title: Professor of Medicine in the Division of Pulmonary and Critical Care Medicine
Kush Desai
Research Area(s) / Expertise:

Venous Disease - General

 Job title: Associate Professor of Radiology, Surgery and Medicine; Director, Deep Venous Interventions
Dr Kush R Desai, MD, FSIR is an Interventional Radiologist and Associate Professor of Radiology, Surgery, and Medicine at Northwestern University. His primary research and clinical interests are in venous thromboembolic disease, deep venous thrombectomy/thrombolysis, reconstruction of chronic venous occlusions, IVC filter management/complex IVC filter retrieval, and interventional pulmonary… View more
Job title: Professor of Angiology / Director University Clinic of Angiology
Prof Nils Kucher is aProfessor of Angiology and Director University Clinic of Angiology at University Hospital Zürich, Zürich, CH. He specialises in minimally invasive endovascular treatment of acute pulmonary embolism, acute deep vein thrombosis, and the post-thrombotic syndrome. From 2016-2017 he was Chief Physician of Angiology at University Hospital Bern, where earlier he fulfilled the… View more
Darko Antic
Job title: Professor of Internal Medicine
Darko Antic is a Professor of Internal Medicine at the Medical Faculty of the University of Belgrade, specializing in lymphoproliferative diseases, with a particular focus on CLL and cancer-associated thrombosis. Recognizing the intersection of hematology and cardiology, Dr. Antic also has expertise in cardio-oncology. He actively contributes to the field as a member of the Scientific & Research… View more